Stockscreener 앱 받기
28.24
0.20%
0.056
전일 마감가:
$28.18
열려 있는:
$28.24
하루 거래량:
26,222
Relative Volume:
0.36
시가총액:
$393.95M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
+0.82%
1개월 성능:
-2.59%
6개월 성능:
-3.52%
1년 성능:
+6.73%
1일 변동 폭
$0.00
$0.00
1주일 범위
$27.82
$28.28
52주 변동 폭
$26.28
$29.97
Elevance Health Inc Stock (EELV) Company Profile
명칭
Elevance Health Inc
전화
404-892-0896
주소
1331 SPRING STREET NW, ATLANTA
Compare EELV vs VOO, IVV, SPY, VTI, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EELV
Elevance Health Inc
|
28.24 | 393.95M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
715.20 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.54 | 896.82B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
778.01 | 821.68B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.32 | 702.31B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
743.57 | 497.30B | 0 | 0 | 0 | 0.00 |
Elevance Health Inc 주식(EELV)의 최신 뉴스
Invesco's AUM Falls in September: Will Growth Momentum Rebound? - Zacks Investment Research
Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research
Why Invesco (IVZ) is a Top Growth Stock for the Long-Term - Zacks Investment Research
Emerging Markets Equities ETFs - ETF Database
Precision Trading with Invesco S&p Emerging Markets Low Volatility Etf (EELV) Risk Zones - Stock Traders Daily
Here's Why Invesco (IVZ) is a Strong Value Stock - Zacks Investment Research
ETFs Investing in Haitian International Holdings Limited Stocks - TradingView
Invesco S&P 500 Low Volatility (SPLWL.XC) Stock Price, News, Quote & History - ca.finance.yahoo.com
Invesco Income Allocation Fund Q2 2026 Commentary (Mutual Fund:ALAAX) - Seeking Alpha
Best Performing ETFs: Top Returns at a Glance - TradingKey
Top ETFs: Live Prices, Returns & Trends - tradingkey.com
Best Performing ETFs: Top Returns at a Glance - TradingKey
Invesco (IVZ) Could Be a Great Choice - Zacks Investment Research
Invesco S&P Emerging Markets Low Volatility ETF declares quarterly distribution of $0.4315 - TradingView
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Bond Market Alarm Puts Invesco Low-Volatility Dividend ETF Back in the Spotlight - finance.biggo.com
ETFs Investing in Beijing Enterprises Holdings Limited Stocks - TradingView
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
7 Best Long-Term ETFs to Buy and Hold | Investing - US News Money
6 Best Dividend Index Funds to Buy in 2026 - The Motley Fool
5 Best Emerging Markets ETFs for 2026 and How to Invest - The Motley Fool
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - TradingView
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - trefis.com
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com Australia
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Reaffirms 2026 Adjusted Earnings Guidance of at Least $27.00 Per Share - minichart.com.sg
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Elevance Health Inc's Dividend Analysis - Yahoo Finance
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Canada
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com Canada
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health Inc (EELV) 재무 분석
Elevance Health Inc (EELV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.20%
0.02%
자본화:
|
볼륨(24시간):